5 products found
Altimmune Inc. Products
-
Model ALT-801 - Dual GLP-1/Glucagon Agonist For NASH
A peptide-based dual GLP-1/glucagon receptor agonist designed to treat the metabolic dysfunction that causes non-alcoholic steatohepatitis (NASH). NASH, the most severe form of non-alcoholic fatty liver disease (NAFLD), involves multiple metabolic pathways leading to the abnormal ...
-
HepTcell - Immunotherapeutic for Chronic Hepatitis B Infections
An immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus (HBV). It is designed to drive CD4+ and CD8+ T-cell responses against all HBV genotypes in patients of diverse genetic backgrounds. Normally, the HBV virus is eliminated through T ...
-
NasoShield - Single Dose Intranasal Anthrax Vaccine
An intranasal vaccine designed to provide rapid, stable protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (“BARDA”) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis ...
-
NasoVAX - Intranasal Flu Vaccine With Diverse Immune Response
A recombinant intranasal vaccine that is being developed for both seasonal and pandemic use. NasoVAX can activate the humoral, mucosal and cellular immune arms in unison for a more comprehensive immune response. The data from our Phase 2a trial with a monovalent NasoVAX vaccine indicated that NasoVAX was well-tolerated and achieved 100% seroprotection with serum antibody responses comparable to a licensed injected influenza ...
-
T-COVID - Single-Dose Intranasal Therapeutic for the Treatment of Early Covid-19
Identical vector technology used for AdCOVID (COVID-19), NasoVAX (seasonal influenza) and NasoShield (anthrax) ...